Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?

Isoglu, Cemal Selcuk; ilbey, yusuf özlem; BOYACIOĞLU, Hayal; türk, hakan; Karabıçak, MUSTAFA; ERGANİ, BATUHAN; Yoldas, Mehmet; Yalbuzdag, Okan Nabi; suelozgen, tufan; ZORLU, Ferruh

Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?

Cemal Selçuk İŞOĞLU, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Tufan SÜELÖZGEN, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Hakan TÜRK, (Dumlupınar Üniversitesi, Tıp Fakültesi, Evliya Çelebi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Kütahya, Türkiye)

Mehmet YOLDAŞ, (Dumlupınar Üniversitesi, Tıp Fakültesi, Evliya Çelebi Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Kütahya, Türkiye)

Mustafa KARABIÇAK, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Batuhan ERGANİ, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Okan Nabi YALBUZDAĞ, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Hayal BOYACIOĞLU, (Ege Üniversitesi, Fen Fakültesi, İstatistik Anabilim Dalı, İzmir, Türkiye)

Yusuf Özlem İLBEY, (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Ferruh ZORLU (Tepecik Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, İzmir, Türkiye)

Journal of Urological Surgery

3 0

Yıl: 2016 Cilt: 3 Sayı: 3 Sayfa Aralığı: 80 - 83 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?

Öz:

Amaç Vücut kitle indeksi (VKİ) 40 kg/m2 üzerinde olan hastaların perkütan nefrolitotomi (PNL) sonuçlarını VKİ normal sınırlarda olan (20-25 kg/m2 hastalardan oluşmuş kontrol grubu ile kıyaslamak amaçlandı. Gereç ve Yöntem VKİ 40 kg/m2 üzerinde olan 30 hasta grup 1 olarak adlandırıldı. İstatistiksel olarak uygun kıyaslama yapabilmek için VKİ normal sınırda olan hastalar arasından random olarak 30 hasta seçildi ve grup 2 olarak adlandırıldı. Gruplar temel demografik veriler, intaoperatif parametreler, taşsızlık ve komplikasyon oranları açısından kıyaslandı. Bulgular Toplam 60 hasta çalışmaya dahil edildi. Demografik veriler ve taş yükü iki grup arasında benzerdi. Gruplar arasında akses sayısı, akses başarısı, operasyon zamanı gibi preoperatif data, taşsızlık ve komplikasyon oranları açısından anlamlı fark saptanmadı. Sonuç PNL morbid obez hastalarda bile güvenli ve etkili bir yöntemdir.

Anahtar Kelime:

Konular: Cerrahi

Morbid Obezite Perkütan Nefrolitotomide Başarı ve Komplikasyon Oranlarını Etkiler mi?

Öz:

Objective To investigate percutaneous nephrolithotomy (PNL) results of morbid obese patients with a body mass index (BMI) of >=40 kg/m2 by comparing with a control group of normal BMI (20-25 kg/m2). Materials and MethodsThirty patients with a BMI of >=40 kg/m2 were randomly assigned to group 1 and 30 patients with a normal BMI (20-25 kg/m2) constituted group 2 as controls. We compared the groups with regard to baseline characteristics, intraoperative parameters, and stone-free and complication rates. Results A total of 60 patients were included in the study. Demographic data and stone burden were similar in both groups. We found no significant differences in access number and success, operative time, and stone-free and complication rates. Conclusion PNL is a safe and effective treatment even for patients with a BMI of >=40 kg/m2.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

C. Türk (Chair), T. Knoll (Vice-chair), A. Petrik, K. Sarica, A. Skolarikos, M. Straub, C. Seitz. Guidelines on Urolithiasis. European Association of Urology 2015. p.16-24.
Calvert RC, Burgess NA. Urolithiasis and obesity: metabolic and technical considerations. Curr Opin Urol 2005;15:113-117.
Koo BC, Burtt G, Burgess NA. Percutaneous stone surgery in the obese: outcome stratified according to body mass index. BJU Int 2004;93:1296- 1299.
Alyami FA, Skinner TA, Norman RW. Impact of body mass index on clinical outcomes associated with percutaneous nephrolithotomy. Can Urol Assoc J 2012;15:1-5.
Finucane MM, Stevens GA, Cowan MJ. National, regional and global trends in body-mass index since 1980: systematic analysis of health examinations surveys and epidemiological studies with 960 country -years and 9.1 million participants. Lancet 2011;377:557-567.
Asplin JR. Obesity and urolithiasis. Adv Chronic Kidney Dis 2009;16:11-20.
Mezentsev VA. Extracorporeal shock wave lithotripsy in the treatment of renal pelvicalyceal stones in morbidly obese patients. Int Braz J Urol 2005;31:105-110.
Dragutescu M, Multescu R, Geavlete B. Impact of obesity on retrograde ureteroscopic approach. J Med Life 2012;5:222-225.
Wheat JC, Roberts WW, Wolf JS Jr. Multi-session retrograde endoscopic lithotripsy of large renal calculi in obese patients. Can J Urol 2009;16:4915- 4920.
Breda A, Ogunyemi O, Leppert JT. Flexible ureteroscopi and laser lithotripsy for multiple unilateral intrarenal stones. Eur Urol 2009;55:1190-1196.
Juvin P, Lavaut E, Dupont H. Difficult tracheal intubation is more common in obese than in lean patients. Anesthesia and Analgesia 2003;97:595-600.
Liu L, Zheng S, Xu Y. Systematic review and meta-analysis of percutaneous nephrolithotomy for patients in the supine versus prone position. J Endourol 2010;24:1941-1946.
Mazzucchi E, Vicentini FC, Marchini GS. Percutaneous nephrolithotomy in obese patients: comparison between the prone and total supine positions. J Endourol 2012;26:1437-1442.
Faerber GJ, Goh M. Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol 1997;3:89-95.
Paerle MS, Nakada SY, Womack JS. Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol 1998;160:669-673.
El-Assmy AM, Shokeir AA, El-Nahas AR. Outcome of percutaneous nephrolithotomy: effect of body mass index. Eur Urol 2007;52:199-204.
Fuller A, Razvi H, Denstedt JD. The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol 2012;188:138-144.

APA	Isoglu C, suelozgen t, türk h, Yoldas M, Karabıçak M, ERGANİ B, Yalbuzdag O, BOYACIOĞLU H, ilbey y, ZORLU F (2016). Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. , 80 - 83.
Chicago	Isoglu Cemal Selcuk,suelozgen tufan,türk hakan,Yoldas Mehmet,Karabıçak MUSTAFA,ERGANİ BATUHAN,Yalbuzdag Okan Nabi,BOYACIOĞLU Hayal,ilbey yusuf özlem,ZORLU Ferruh Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. (2016): 80 - 83.
MLA	Isoglu Cemal Selcuk,suelozgen tufan,türk hakan,Yoldas Mehmet,Karabıçak MUSTAFA,ERGANİ BATUHAN,Yalbuzdag Okan Nabi,BOYACIOĞLU Hayal,ilbey yusuf özlem,ZORLU Ferruh Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. , 2016, ss.80 - 83.
AMA	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. . 2016; 80 - 83.
Vancouver	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. . 2016; 80 - 83.
IEEE	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F "Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?." , ss.80 - 83, 2016.
ISNAD	Isoglu, Cemal Selcuk vd. "Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?". (2016), 80-83.

APA	Isoglu C, suelozgen t, türk h, Yoldas M, Karabıçak M, ERGANİ B, Yalbuzdag O, BOYACIOĞLU H, ilbey y, ZORLU F (2016). Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. Journal of Urological Surgery, 3(3), 80 - 83.
Chicago	Isoglu Cemal Selcuk,suelozgen tufan,türk hakan,Yoldas Mehmet,Karabıçak MUSTAFA,ERGANİ BATUHAN,Yalbuzdag Okan Nabi,BOYACIOĞLU Hayal,ilbey yusuf özlem,ZORLU Ferruh Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. Journal of Urological Surgery 3, no.3 (2016): 80 - 83.
MLA	Isoglu Cemal Selcuk,suelozgen tufan,türk hakan,Yoldas Mehmet,Karabıçak MUSTAFA,ERGANİ BATUHAN,Yalbuzdag Okan Nabi,BOYACIOĞLU Hayal,ilbey yusuf özlem,ZORLU Ferruh Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. Journal of Urological Surgery, vol.3, no.3, 2016, ss.80 - 83.
AMA	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. Journal of Urological Surgery. 2016; 3(3): 80 - 83.
Vancouver	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?. Journal of Urological Surgery. 2016; 3(3): 80 - 83.
IEEE	Isoglu C,suelozgen t,türk h,Yoldas M,Karabıçak M,ERGANİ B,Yalbuzdag O,BOYACIOĞLU H,ilbey y,ZORLU F "Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?." Journal of Urological Surgery, 3, ss.80 - 83, 2016.
ISNAD	Isoglu, Cemal Selcuk vd. "Does Morbid Obesity Adversely Affect Success and Complication Rates in Percutaneous Nephrolithotomy?". Journal of Urological Surgery 3/3 (2016), 80-83.